Atypical Wiskott-Aldrich syndrome without thrombocytopenia partially responding to omalizumab therapy. Gupta P, Subburaj K, Jindal A, Rawat A, et al. Clin Exp Dermatol 2022;47:1013-1016.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gupta P, Subburaj K, Jindal A, Rawat A, et al. Atypical Wiskott-Aldrich syndrome without thrombocytopenia partially responding to omalizumab therapy. Clin Exp Dermatol 2022;47:1013-1016.
PMID: 35249234